GLP-1 drugs to carry warning about rare vision-loss side effect, FDA says
Summary
The FDA says GLP-1 drugs will carry a warning about a rare side effect that can lead to vision loss. Dr. Rachel Pessah-Pollack discussed the warning with CBS News.Key Facts
- The FDA announced a new side-effect warning for GLP-1 drugs.
- The warning concerns a rare side effect.
- The side effect can lead to vision loss.
- The FDA described the potential outcome as dangerous.
- Dr. Rachel Pessah-Pollack joined CBS News to discuss the warning.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.